Exelixis Announces Detailed Results of Phase 3 CONTACT-02 Pivotal Trial Evaluating Cabozantinib in Combination with Atezolizumab in Metastatic Castration-Resistant Prostate Cancer Presented at ASCO GU 2024
– Cabozantinib in combination with atezolizumab reduced the risk of disease progression or death by 35% in patients with metastatic castration-resistant prostate... Read more.
Plastic Collective attracts landmark fundraising to tackle plastic pollution
LONDON & WASHINGTON–(BUSINESS WIRE)–Plastic Collective, a leading social enterprise focused on solving the plastic waste epidemic, is pleased to... Read more.
Domain Therapeutics Awarded Hospital-University Research in Health (RHU) SPRINT Consortium Grant to Progress Its Proprietary CCR8 Antibody Candidate to the Clinic
Domain to receive a grant over a five year period to support DT-7012 which is expected to start a Phase I study by mid-2025 DT-7012, a Treg depleting anti-CCR8 monoclonal... Read more.
Energy Vault Expands Global Footprint for Gravity Energy Storage with 10 Year License and Royalty Agreement Covering Southern Africa
License executed with GESSOL (Pty), a South Africa-based consortium including WBHO, one of the largest listed EPC companies in Southern Africa (JSE: WBO), iX Engineers... Read more.
European Medical Devices Regulatory Affairs Handbook 2024 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “European Handbook of Medical Devices Regulatory Affairs 2024” directory has been added to ResearchAndMarkets.com’s... Read more.
Credit Benchmark says US financial institutions’ low default rate will rise in 2024, as discussed in 2024 Default Risk Outlook report on 13 US industries
NEW YORK–(BUSINESS WIRE)–#banking–Credit Benchmark, the provider of global consensus ratings and analytics, today said that the low 0.6% default... Read more.
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today that it will present... Read more.
SolarWinds to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, and Present at Upcoming Investor Conferences
AUSTIN, Texas–(BUSINESS WIRE)–SolarWinds (NYSE:SWI), a leading provider of simple, powerful, secure observability and IT management software, today announced... Read more.
LLCP Hires Brian Klaban as Head of Capital Markets and Director of Originations
LOS ANGELES–(BUSINESS WIRE)–Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced today that Brian Klaban... Read more.
NETSCOUT Reports Third Quarter Fiscal Year 2024 Financial Results
WESTFORD, Mass.–(BUSINESS WIRE)–NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT), a leading provider of performance management, cybersecurity, and DDoS attack protection... Read more.